We are an awesome team working on improving the health of both patients and nurses.

CYTO365 CEO and Founder

Micael Törnblom

CEO & Founder

Product Manager RondelO™ IV-set at CYTO365
Ida Virtala

Product Manager IV-sets

R&D RondelO™ at CYTO365
Patrik Gerenmark

R&D Specialist

Monique Feikes de Groot

QA Manager

CYTO365 Head of Board
Mats Dörring

Chairman of the Board

CYTO365 Boardmember
Arne Nilsson

Board Member

CYTO365 Suppleant Boardmember
Olle Nilsson

Board Member

CYTO365 Boardmember
Håkan Svanberg

Board Member

CYTO365 Boardmember
Fredrik Lüning

Board Member

CYTO365 Boardmember
Linda Berndtsson

RA / Board Member

Open Positions

We see a rapid expansion this year and we are always looking to connect with more enthusiastic people within this field.
We are currenly seeking to fill the following positions: 

The company

CYTO365 AB is a small startup company that is already ten years old with global ambitions. After a long take-off run, the first product will be launched shortly. It is an aim that RondelO™ will become the new standard component within infusion therapy for drugs that should be given in sequence.


We invests heavily in our patent portfolio and hold multiple approved patents worldwide within infusion technology covering about 50% of worlds population.


of worlds population

- aid nurses to do right

Report deviation

In case you experience a deviation with any of our products, please fill in this form or send us an e-mail at pms@cyto365.com